Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Arcosa, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-64.4% vs price
Base Case (Median)
-39.4% vs price
Bull Case (75th pct.)
3.7% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $77.10 | -47.4% | High (40%) |
| PE Comparable | $193.90 | 32.4% | Medium (25%) |
| Growth Trajectory DCF | $220.23 | 50.3% | Medium (20%) |
| Graham Number | $109.91 | -25.0% | High (80%) |
| EV/EBITDA | $88.82 | -39.4% | Medium (20%) |
| EV/FCF | $27.17 | -81.5% | Medium (20%) |
| Earnings Power Value | $21.14 | -85.6% | High (70%) |
Based on 7 out of 7 methods, ACA appears fairly valued at the current price of $146.50. The base case fair value of $88.82 implies 39.4% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.